Journal Mobile Options
Table of Contents
Vol. 99, No. 1-4, 2002
Issue release date: 2002
Cytogenet Genome Res 99:297–302 (2002)

Microphthalmia with linear skin defects syndrome (MLS): a male with a mosaic paracentric inversion of Xp

Kutsche K. · Werner W. · Bartsch O. · von der Wense A. · Meinecke P. · Gal A.
aInstitut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg; bInstitut für Klinische Genetik, Medizinische Fakultät der Technischen Universität Dresden, Dresden; cAbteilung für Neonatologie und pädiatrische Intensivmedizin, dAbteilung für Medizinische Genetik, Altonaer Kinderkrankenhaus, Hamburg (Germany)

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The microphthalmia with linear skin defects syndrome (MLS) is an X-linked dominant disorder with male lethality. In the majority of the patients reported, the MLS syndrome is caused by segmental monosomy of the Xp22.3 region. To date, five male patients with MLS and 46,XX karyotype (“XX males”) have been described. Here we report on the first male case with MLS and an XY complement. The patient showed agenesis of the corpus callosum, histiocytoid cardiomyopathy, and lactic acidosis but no microphthalmia, and carried a mosaic subtle inversion of the short arm of the X chromosome in 15% of his peripheral blood lymphocytes, 46,Y,inv(X)(p22.13∼22.2p22.32∼22.33)[49]/46,XY[271]. By fluorescence in situ hybridization (FISH), we showed that YAC 225H10 spans the breakpoint in Xp22.3. End-sequencing and database analysis revealed a YAC insert of at least 416 kb containing the genes HCCS and AMELX, and exons 2–16 of ARHGAP6. Molecular cytogenetic data suggest that the Xp22.3 inversion breakpoint is located in intron 1 of ARHGAP6, the gene encoding the Rho GTPase activating protein 6. Future molecular studies in karyotypically normal female MLS patients to detect submicroscopic rearrangements including the ARHGAP6 gene as well as mutation screening of ARHGAP6 in patients with no obvious chromosomal rearrangements will clarify the role of this gene in MLS syndrome.    

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Al-Gazali LI, Mueller RF, Caine A, Antoniou A, McCartney A, Fitchett M, Dennis NR: Two 46,XX,t(X;Y) females with linear skin defects and congenital microphthalmia: a new syndrome at Xp22.3. J med Genet 27:59–63 (1990).
  2. Allanson J, Richter S: Linear skin defects and congenital microphthalmia: a new syndrome at Xp22.2. J med Genet 28:143–144 (1991).
  3. Andreu AL, Checcarelli N, Iwata S, Shanske S, DiMauro S: A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy. Pediatr Res 48:311–314 (2000).
  4. Anguiano A, Yang X, Felix JK, Hoo JJ: Twin brothers with MIDAS syndrome and XX karyotype. Am J med Genet in press (2003).
  5. Armstrong J, Pineda M, Aibar E, Gean E, Monros E: Classic Rett syndrome in a boy as a result of somatic mosaicism for an MECP2 mutation. Ann Neurol 50:692 (2001).
  6. Ballabio A, Andria G: Deletions and translocations involving the distal short arm of the human X chromosome: review and hypotheses. Hum molec Genet 1:221–227 (1992).
  7. Ballabio A, Bardoni B, Guioli S, Basler E, Camerino G: Two families of low-copy-number repeats are interspersed on Xp22.3: implications for the high frequency of deletions in this region. Genomics 8:263–270 (1990).
  8. Bardoni B, Guioli S, Raimondi E, Heilig R, Mandel JL, Ottolenghi S, Camerino G: Isolation and characterization of a family of sequences dispersed on the human X chromosome. Genomics 3:32–38 (1988).
  9. Bartsch O, Wagner A, Hinkel GK, Krebs P, Stumm M, Schmalenberger B, Böhm S, Balci S, Majewski F: FISH studies in 45 patients with Rubinstein-Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy. Eur J hum Genet 7:748–756 (1999).
  10. Bird LM, Krous HF, Eichenfield LF, Swalwell CI, Jones MC: Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy? Am J med Genet 53:141–148 (1994).
  11. Brown RM, Dahl HH, Brown GK: X-chromosome localization of the functional gene for the E1 alpha subunit of the human pyruvate dehydrogenase complex. Genomics 4:174–181 (1989).
  12. Camacho JA, Goodman BK, Hamosh A, Hurko O, Thomas GH: MIDAS syndrome in a 46,XX newborn with ambiguous genitalia and a cryptic, de novo X;Y translocation. Am J hum Genet Suppl 61:A93 (1997).
  13. Clayton-Smith J, Watson P, Ramsden S, Black GC: Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 356:830–832 (2000).
  14. Cox TC, Cox LL, Ballabio A: A very high density microsatellite map (1 STR/41 kb) of 1.7 Mb on Xp22 spanning the microphthalmia with linear skin defects (MLS) syndrome critical region. Eur J hum Genet 6:406–412 (1998).
  15. Dahl HH, Brown GK, Brown RM, Hansen LL, Kerr DS, Wexler ID, Patel MS, De Meirleir L, Lissens W, Chun K, et al: Mutations and polymorphisms in the pyruvate dehydrogenase E1 alpha gene. Hum Mutat 1:97–102 (1992).
  16. Donnenfeld AE, Graham JM Jr, Packer RJ, Aquino R, Berg SZ, Emanuel BS: Microphthalmia and chorioretinal lesions in a girl with an Xp22.2→pter deletion and partial 3p trisomy: clinical observations relevant to Aicardi syndrome gene localization. Am J med Genet 37:182–186 (1990).
  17. Eng A, Lebel RR, Elejalde BR, Anderson C, Bennett L: Linear facial skin defects associated with microphthalmia and other malformations, with chromosome deletion Xp22.1. J Am Acad Dermatol 31:680–682 (1994).
  18. Ferrero GB, Franco B, Roth EJ, Firulli BA, Borsani G, Delmas-Mata J, Weissenbach J, Halley G, Schlessinger D, Chinault AC, et al: An integrated physical and genetic map of a 35 Mb region on chromosome Xp22.3→Xp21.3. Hum molec Genet 4:1821–1827 (1995).
  19. Friedman PA, Rao KW, Teplin SW, Aylsworth AS: Provisional mapping deletion of the focal dermal hypoplasia (FDH) gene to Xp22.31. Am J hum Genet Suppl 43:A450 (1988).
  20. Gericke GS, Myburgh E, Bester R, van Rensberg EJ, Neethling E: Further delineation of the Xp22.2→pter syndrome of linear skin lesions, microphthalmia and anterior chamber eye anomalies. Am J hum Genet Suppl 49:A271 (1991).
  21. Happle R, Daniels O, Koopman RJ: MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome. Am J med Genet 47:710–713 (1993).
  22. Ji Y, Eichler EE, Schwartz S, Nicholls RD: Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 10:597–610 (2000).
  23. Kayserili H, Cox TC, Cox LL, Basaran S, Kilic G, Ballabio A, Yuksel-Apak M: Molecular characterisation of a new case of microphthalmia with linear skin defects (MLS). J med Genet 38:411–417 (2001).
  24. Kenwrick S; The International IP Consortium: Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J hum Genet 69:1210–1217 (2001).
  25. Kono T, Migita T, Koyama S, Seki I: Another observation of microphthalmia in an XX male: microphthalmia with linear skin defects syndrome without linear skin lesions. J hum Genet 44:63–68 (1999).
  26. Lagerstrom M, Dahl N, Nakahori Y, Nakagome Y, Backman B, Landegren U, Pettersson U: A deletion in the amelogenin gene (AMG) causes X-linked amelogenesis imperfecta (AIH1). Genomics 10:971–975 (1991).
  27. Lindor NM, Michels VV, Hoppe DA, Driscoll DJ, Leavitt JA, Dewald GW: Xp22.3 microdeletion syndrome with microphthalmia, sclerocornea, linear skin defects, and congenital heart defects. Am J med Genet 44:61–65 (1992).
  28. Lindsay EA, Grillo A, Ferrero GB, Roth EJ, Magenis E, Grompe M, Hulten M, Gould C, Baldini A, Zoghbi HY, et al.: Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic, and molecular characterization. Am J med Genet 49:229–234 (1994).
  29. Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, Ito M, Naito E, Kuroda Y, Kerr DS, Wexler ID, Patel MS, Robinson BH, Seyda A: Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 15:209–219 (2000).
  30. Martinez-Garay I, Jablonka S, Sutajova M, Steuernagel P, Gal A, Kutsche K: A new gene family (FAM9) of low-copy repeats in Xp22.3 expressed exclusively in testis: implications for recombinations in this region. Genomics 80:259–267 (2002).
  31. Mazzarella R, Schlessinger D: Pathological consequences of sequence duplications in the human genome. Genome Res 8:1007–1021 (1998).
  32. McLeod SD, Sugar J, Elejalde BR, Eng A, Lebel RR: Gazali-Temple syndrome. Arch Ophthalmol 112:851–852 (1994).
  33. Metzenberg AB, Kelley R, Smith D, Kopacz K, Sutphen R, Sheffield L, Herman G: Mutations in chondrodysplasia punctata, X-linked dominant type (CDPX2). Am J hum Genet Suppl 65:A480 (1999).
  34. Mücke J, Happle R, Theile H: MIDAS syndrome respectively MLS syndrome: a separate entity rather than a particular lyonization pattern of the gene causing Goltz syndrome. Am J med Genet 57:117–118 (1995).
  35. Naritomi K, Izumikawa Y, Nagataki S, Fukushima Y, Wakui K, Niikawa N, Hirayama K: Combined Goltz and Aicardi syndromes in a terminal Xp deletion: are they a contiguous gene syndrome? Am J med Genet 43:839–843 (1992).
  36. Nehls M, Luno K, Schorpp M, Pfeifer D, Krause S, Matysiak-Scholze U, Dierbach H, Boehm T: YAC/P1 contigs defining the location of 56 microsatellite markers and several genes across a 3.4-cM interval on mouse chromosome 11. Mammal Genome 6:321–331 (1995).
  37. Ogata T, Wakui K, Muroya K, Ohashi H, Matsuo N, Brown DM, Ishii T, Fukushima Y: Microphthalmia with linear skin defects syndrome in a mosaic female infant with monosomy for the Xp22 region: molecular analysis of the Xp22 breakpoint and the X-inactivation pattern. Hum Genet 103:51–56 (1998).
  38. Paulger BR, Kraus EW, Pulitzer DR, Moore CM: Xp microdeletion syndrome characterized by pathognomonic linear skin defects on the head and neck. Pediatr Dermatol 14:26–30 (1997).
  39. Prakash SK, Cormier TA, McCall AE, Garcia JJ, Sierra R, Haupt B, Zoghbi HY, Van Den Veyver IB: Loss of holocytochrome c-type synthetase causes the male lethality of X-linked dominant microphthalmia with linear skin defects (MLS) syndrome. Hum molec Genet 11:3237–3248 (2002).
  40. Prakash SK, Paylor R, Jenna S, Lamarche-Vane N, Armstrong DL, Xu B, Mancini MA, Zoghbi HY: Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA. Hum molec Genet 9:477–488 (2000).
  41. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W, Feldman GJ, Volta M, Andolfi G, Gilgenkrantz S, Marion RW, Hennekam RC, Opitz JM, Muenke M, Ropers HH, Ballabio A: Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nature Genet 17:285–291 (1997).
  42. Schaefer L, Ballabio A, Zoghbi HY: Cloning and characterization of a putative human holocytochrome c-type synthetase gene (HCCS) isolated from the critical region for microphthalmia with linear skin defects (MLS). Genomics 34:166–172 (1996).
  43. Schaefer L, Prakash S, Zoghbi HY: Cloning and characterization of a novel rho-type GTPase-activating protein gene (ARHGAP6) from the critical region for microphthalmia with linear skin defects. Genomics 46:268–277 (1997).
  44. Schwarz QP, Cox TC: Complementation of a yeast CYC3 deficiency identifies an X-linked mammalian activator of apocytochrome c. Genomics 79:51–57 (2002).
  45. Stratton RF, Walter CA, Paulgar BR, Price ME, Moore CM: Second 46,XX male with MLS syndrome. Am J med Genet 76:37–41 (1998).
  46. Temple IK, Hurst JA, Hing S, Butler L, Baraitser M: De novo deletion of Xp22.2→pter in a female with linear skin lesions of the face and neck, microphthalmia, and anterior chamber eye anomalies. J med Genet 27:56–58 (1990).
  47. Thies U, Rao VV, Engel W, Schmidtke J: Physical mapping of two Xp markers DXS16 and DXS143. Hum Genet 86:418–420 (1991).
  48. Topçu M, Akyerli C, Sayi A, Toruner GA, Kocoglu SR, Cimbis M, Ozcelik T: Somatic mosaicism for an MECP2 mutation associated with classic Rett syndrome in a boy. Eur J hum Genet 10:77–81 (2002).
  49. Van den Veyver IB: Skewed X inactivation in X-linked disorders. Semin Reprod Med 19:183–191 (2001).
  50. Wapenaar MC, Bassi MT, Schaefer L, Grillo A, Ferrero GB, Chinault AC, Ballabio A, Zoghbi HY: The genes for X-linked ocular albinism (OA1) and microphthalmia with linear skin defects (MLS): cloning and characterization of the critical regions. Hum molec Genet 2:947–952 (1993).
  51. Wapenaar MC, Schiaffino MV, Bassi MT, Schaefer L, Chinault AC, Zoghbi HY, Ballabio A: A YAC-based binning strategy facilitating the rapid assembly of cosmid contigs: 1.6 Mb of overlapping cosmids in Xp22. Hum molec Genet 3:1155–1161 (1994).
  52. Werner W, Spiegler AW: Inherited deletion of subband Xp21.13 in a male with Duchenne muscular dystrophy. J Med Genet 25:377–382 (1988).
  53. Zvulunov A, Kachko L, Manor E, Shinwell E, Carmi R: Reticulolinear aplasia cutis congenita of the face and neck: a distinctive cutaneous manifestation in several syndromes linked to Xp22. Br J Dermatol 138:1046–1052 (1998).

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50